MSc in Integrated Immunology

The MSc Integrated Immunology was established in 2004, and has admitted over 250 students in this time. The vast majority of our alumni have remained in science or medicine. Approximately 40% of those who have graduated from the course have gone on to enrol for PhDs (around half have stayed in Oxford for their studies) with many now working as post-doctoral researchers and fellows. A further 10% have entered medical school, with others who were already qualified clinicians before enrolling on the MSc returning to higher specialist training.

Thoughts from our alumni

KUAN-HSIANG GARY HUANG - DIRECTOR OF IMMUNOLOGY CLINICAL DEVELOPMENT AT JANSSEN (CLASS OF 2005/06)

'Professionally, I currently work in clinical pharmaceutical R&D at Johnson & Johnson on inflammatory bowel disease Ph2/3 clinical trials. I enjoy the career and challenges in immunology R&D, despite the trying pandemic. I'm grateful to the foundation laid by the MSc in my career journey through R&D at Bristol-Myers Squibb, clinical allergy/immunology/medicine practices at Einstein Philadelphia, Hospital of University of Pennsylvania and Children's Hospital of Philadelphia and DPhil in Internal Medicine at Oxford.'

ADAM DMYTRIW - CLINICAL FELLOW, NEURORADIOLOGY & INTERVENTION, BRIGHAM AND WOMEN'S HOSPITAL (CLASS OF 2009/10)

Adam Dmytriw (class of 2009/10) proceeded to medical school and specialised in Neuroradiology & Intervention, with additional research training at the Krembil Research Institute, Toronto Western Hospital. Focusing on neuroimmunology and multicentre trials in cerebrovascular disease, he proceeded to earn a second graduate degree in public health as well as subspecialty training at Harvard University. He has led numerous research endeavours in diagnostic and interventional neuroradiology, the results of which have been presented nationally and internationally. He credits the Integrated Immunology program with providing an invaluable foundation for his development, both with regards to understanding disease pathophysiology and in managing research projects.

CAITLIN MULLARKEY - ASSISTANT PROFESSOR AND ASSOCIATE CHAIR, BIOCHEMISTRY UNDERGRADUATE EDUCATION, MCMASTER UNIVERSITY (CLASS OF 2009/10)

'I have the MSc in Integrated Immunology to thank for kick-starting my career in virology immunology. Prior to Oxford, I had a very broad liberal arts biology and chemistry education, and I specifically selected the program to gain cutting-edge immunological training. While in the program I had the opportunity to learn from world leadering experts and hone my skills in a wide breadth of fundamental and clinical topics. My lab placement at the Jenner Institute led me to pursue a DPhil in Clinical Medicine under the supervision of Dr. Sarah Gilbert and Teresa Lambe. During my time as a graduate student, I evaluated a novel immunization strategy using a candidate influenza vaccine that eventually reached Phase IIB testing. I went on to complete a postdoctoral fellowship with Dr. Peter Palese, a world-renowned influenza virologist, at the Icahn School of Medicine at Mount Sinai in New York.  As a postdoctoral fellow I continued to advance my training in virology, infection and immunity. During my time in the Palese laboratory, I was involved in several projects with the central theme of understanding the mechanisms by which broadly-neutralizing hemagglutinin stalk-reactive antibodies mediate protection. The scope of this work allowed me to combine my knowledge in immunology, microbiology, and host-pathogen interactions to execute studies that ultimately inform clinical vaccine development. I am currently an Assistant Professor in the Department of Biochemistry and Biomedical Sciences at McMaster University, where I am also the Associate Chair of Undergraduate Education. In addition to research, I teach virology, cell biology, biochemistry, and immunology to undergraduates at all levels.'

PHILEMON GYASI-ANTWI - BBSRC RESEARCH FELLOW, TRANSLATIONAL MEDICAL SCIENCES UNIT, UNIVERSITY OF NOTTINGHAM (CLASS OF 2012/13)

'I went on to complete a Ph.D. in Immunology at the University of Nottingham, where I am now a BBSRC Research Fellow working on a cross-disciplinary project to investigate the interplay between lung epithelial cells and macrophages during SARS-CoV-2 infection. 

The MSc Integrated Immunology provided me a solid background in the fundamental science of immunology and helped me develop a research interest in host-pathogen interactions. It was one of my best times—having had the opportunity to interact with 14 other colleagues from different backgrounds and being taught by experts in the field.'

JACLYN LYMAN - DIRECTOR OF PANCREATIC PROGRAMS AND CLINICAL SCIENCE, PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (CLASS OF 2014/15)

'While working at Memorial Sloan Kettering Cancer Center, I became fascinated by immuno-oncology.  This led me to pursue the MSc course with the intention of gaining a deeper understanding of immunological principles and their clinical applications in order to bring this knowledge to my career in clinical research.  After completing the course as part of the 2014/2015 cohort, including an autophagy-based research project in Professor Katja Simon's lab, I joined the the Parker Institute for Cancer Immunotherapy (PICI), launched in mid-2016.  Without question, the deep scientific knowledge gained on the course has directly impacted my continued career growth and ability to perform many roles at PICI, most specifically helping design and analyze immuno-oncology clinical trials.'

ATHENA CAVOUNIDIS - DPHIL STUDENT IN NUFFIELD DEPARTMENT OF CLINICAL MEDICINE (CLASS OF 2015/16)

'I was in the 2015/2016 MSc cohort and conducted my research project in Holm Uhlig’s lab. Subsequently, I stayed as a research assistant to continue the research I started during my MSc project. I was awarded an NDM Prize Studentship and an MRC-DTP scholarship to pursue my DPhil (2017-2021) on monogenic diseases and immune dysregulation in the Uhlig lab. I feel that this MSc paved the way for my being accepted onto the DPhil program, since it provided me with a strong foundation in immunology and gave me the chance to carry out cutting edge research. I am currently the Chair of the Oxford Immunology Group and have contributed to the COVID-19 response through a literature initiative.'